Summaries of the Section H (HML) update
Each month we issue a summary of the HML update. The table on this page gives a preview of the upcoming changes.
The table on this page gives a preview of the upcoming changes that will be announced in next month’s Section H of the Pharmaceutical Schedule.
The changes will be published in the Online HML(external link) around the 23rd of this month and are effective from next month.
For any questions about these listing changes or the Pharmaceutical Schedule in general, email us at enquiry@pharmac.govt.nz.
17 July 2025 - preview of changes for August 2025
Pharmaceutical |
Change |
---|---|
Azithromycin (Zithromax) tab 500 mg |
price increase and addition of PSS |
Daunorubicin (Pfizer) inj 18.7 mg vial |
new listing (p’code 2710986) |
Daunorubicin (Pfizer) inj 2 mg per ml, 10 ml vial |
to be delisted 1 January 2026 |
Dulaglutide (Trulicity) inj 1.5 mg per 0.5 ml prefilled pen |
amended restriction criteria |
Ephedrine (Ephedrine Juno) inj 3 mg per ml, 10 ml syringe |
new listing and addition of PSS (p’code 2709015) |
Ephedrine (Ephedrine Aguettant) inj 3 mg per ml, 10 ml syringe |
brand name change and removal of PSS |
Hydrogen peroxide (Crystaderm) crm 1% |
Pack size change
|
Irinotecan hydrochloride (Accord) inj 20 mg per ml, 25 ml vial |
new listing (p’code 2711036) |
Ispaghula (Psyllium) husk (Konsyl-D) powder for oral soln |
price increase and amended PSS |
Ketamine (Ketamine-Baxter) inj 100 mg per ml, 2 ml vial |
to be delisted 1 November 2025 |
Lenalidomide (Viatris) (Lenalidomide Viatris) cap 10 mg |
new Pharmacode listing (p’code 2707535) |
Liraglutide (Victoza) inj 6 mg per ml, 3 ml prefilled pen |
amended restriction criteria |
Macrogol 3350 with potassium chloride, sodium bicarbonate and sodium chloride (Molaxole) powder for oral soln 13.125 g with potassium chloride 46.6 mg, sodium bicarbonate 178.5 mg and sodium chloride 350.7 mg |
price increase and amended PSS date |
Macrogol 3350 with potassium chloride, sodium bicarbonate and sodium chloride (Movicol) powder for oral soln 13.125 g with potassium chloride 46.6 mg, sodium bicarbonate 178.5 mg and sodium chloride 350.7 mg |
new listing (p’code 2194864) |
Mirtazapine (Noumed) tab 30 mg and 45 mg |
price decrease and addition of PSS |
Pegylated interferon alfa-2a (Pegasys (S29)) inj 135 mcg prefilled syringe |
new listing (p’code 2710994) |
Riboflavin 5-phosphate inj 0.1% plus hydroxypropryl methylcellulose |
new listing |
Salbutamol (UK Cipla) nebuliser soln, 1 mg per ml, 2.5 ml ampoule |
new listing (p’code 2710811) |
Sodium phosphate with phosphoric acid (Fleet Phosphate Enema) enema 10% with phosphoric acid 6.58% |
price increase |
Valganciclovir (Valganciclovir Viatris) tab 450 mg |
amended restriction criteria |
Water (Fresenius Kabi) inj 10 ml ampoule |
new listing (p’code 2565684) |